|
Session 157
Poster Abstracts
Lymphoma and Kaposi's Sarcoma Pathogenesis and Impact of Treatment
Tuesday, 1 - 4 pm
Poster Hall |
| 876 |
KSHV Infection and Replication in Systemic Reconstituted SCID-hu Thy/Liv Mice
Anja Kathrin Wege*1, F Othieno1, K Staskus2, P Denton1, A Padgett-Thomas1, Z Sun1, M Melkus1, D Ganem3, R Saad4, and J Garcia1
1Univ of Texas Southwestern Med Ctr, Dallas, US; 2Univ of Minnesota Med Sch, Minneapolis, US; 3Howard Hughes Med Ctr, San Francisco, CA, US; and 4Baylor Univ Med Ctr, Dallas, TX, US |
| 877 |
Lack of Age Dependence in KSHV Seroprevalence among Children in a Population-based Study in South Africa: Evidence for at Least 2 Epidemiologic Patterns of KSHV Transmission in Africa
Lisa Butler*1, A Mosam2, P Kiepiela2, G Mbisa3, D Whitby3, C Brander4, D Scadden4, S Dollard5, and J Martin1
1Univ of California, San Francisco, US; 2Univ of KwaZulu Natal, Durban, South Africa; 3NCI-Frederick, MD, US; 4AIDS Malignancy Consortium, Baltimore, MD, US; and 5CDC, Atlanta, GA, US |
| 878 |
Predicting the Evolution of KS, in the HAART Era
Emmanuelle Boffi El Amari*1, L Trellu1, M Baumann2, G Cathomas2, I Steffen3, P Erb3, N Mueller4, B Hirschel1, and the Swiss HIV Cohort Study
1Univ Hosp Geneva, Switzerland; 2Pathology Inst, Liestal, Switzerland; 3Microbio Inst, Basel, Switzerland; and 4Univ Hosp, Zurich, Switzerland |
| 879 |
Improved Survival of AIDS/KS Treated with Co-formulated Abacavir/Lamivudine/Zidovudine in Zimbabwe
Margaret Borok*1, I Gudza1, S Fiorillo2, B Ndemera1, B Putnam2, E Loeliger3, L Gwanzura1, R Schooley4, and T Campbell2
1Univ of Zimbabwe Coll of Hlth Sci, Harare; 2Univ of Colorado Hlth Sci Ctr, Denver, US; 3GlaxoSmithKline, London, UK; and 4Univ of California, San Diego, US |
880
 |
Clinical Outcomes of HIV-infected Patients with Kaposi's Sarcoma Disease Receiving ART in Rural Uganda
Fred Asiimwe*1, D Moore1,2, D Moore1,2, R Nakityo1, W Were1, J Mermin1, and F Kaharuza1
1Global AIDS Prgm, CDC, Uganda, Entebbe and 2BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada |
881
|
HAART Is Not Associated with an Increased Risk of Hodgkin Lymphoma in HIV-infected Patients
Fabrice Bonnet*1, K Petoumenos2, A Calmy3, C Lewden1, J Hoy4, F Dabis1, S Herbert4, P Morlat1, A Carr3, M Law2, and the Aquitaine Cohort and the Australian HIV Observationnal Database
1INSERM U593, Univ Bordeaux 2, France; 2Natl Ctr for HIV Epidemiology and Clin Res, Univ of New South Wales, Australia; 3St Vincent's Hosp, Sydney, Australia; and 4Alfred Hosp, Melbourne, Australia |
882
|
High Intensive Chemotherapy Regimen (LMB 86) for Saint Jude Stage IV AIDS-related Burkitt Lymphoma/Leukemia : A Prospective Study
L Galicier, Laurence Gérard*, C Fieschi, R Borie, V Meignin, M T Daniel, and E Oksenhendler
St Louis Hosp, Paris, France |
|
